Department of Internal Medicine
Hematology, Oncology and Blood & Marrow Transplantation Faculty
Roger D. Gingrich, M.D., Ph.D.
Dr. Gingrich's research interests focus on clinical studies on bone marrow transplantation. Two specific areas of his research involve protocols that tailor for each patient the balance of the risk and benefit of graft versus host disease in patients receiving allogeneic BMT; and studies of intensive salvage therapy combined with autologous hemopoietic stem cell transplantation for patients with breast cancer.
Honors, Awards, and Organizations
- Alison Eberlein Award
- Alpha Omega Alpha
- American Association for the Advancement of Science
- Diplomate, American Board of Internal Medicine American Council on Transplantation
- American Society for Transplant Physicians
- American Society for Hematology
- Hartford Fellowship
- International Society of Experimental Hematology
- Mosby Award
- deMagalhaes-Silverman, M., Lee, C.K., Hohl, R., Schlueter, A., Ritchie, J., Gingrich, R. Allergenic Transplantation of CD34+ Selected Peripheral Blood Progenitors Cells from HLA Matched Identical Siblings Followed by Pre-Emptive T-Cell Add-Back: A Feasibility Study. Stem Cell and Cellular Therapy. 1, 21-28, 2003.
- Lee, C.K., deMagalhaes-Silverman, M., Hohl, R.J., Hayashi, M., Buatti, J., Wen, B.C., Schlueter, A., Strauss, R., Gingrich, R.D. Donor T lymphocyte infusion for unrelated allergenic bone marrow transplantation with CD3+ T-cell depleted graft, accepted, 2002.
- Lee, C.K., deMagalhaes-Silverman, M., Hayashi, M., Schlueter, A., Strauss, R.G., Hohl, R.J., Gingrich, R.D. High-dose chemotherapy A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation. Bone Marrow Transplantation, 29, 647-652, 2002.
Links of Interest